Company: FTII
Filing Date: 2025-08-18
Form Type: 8-K
Source: 0001641172-25-024668
Chunk: 1

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-08-18
Form: 8-K
Item: Item 1.01
Chunk 1
---
 agreement with Aegeria
(the “ Waiver Agreement”) to remove the restriction contained in the Aegeria Acquisition Agreement that prohibited
Aegeria from soliciting, negotiating, entering into, or otherwise facilitating an acquisition proposal or alternative transaction.

The
foregoing description of the Approval of Waiver and the Waiver Agreement does not purport to be complete and is qualified in its entirety
by the terms and conditions of the Approval of Waiver and the Waiver Agreement and any related agreements.

A
copy of the Approval of Waiver and the Waiver Agreement are filed with this Current Report as Exhibits 10.1 and 10.2, respectively and
are incorporated herein by reference.

Item
9.01. Financial Statements and Exhibits.

(c)
Exhibits.

The
following exhibits are filed as part of, or incorporated by reference into, this Report.

  No.        Description                                                                                        
             of Exhibit                                                                                         
  10.1*      Approval of Waiver, August 12, 2025, between FutureTech II, LLC and Longevity Biomedical, Inc.     
  10.2       Waiver Agreement, August 12, 2025, between Longevity Biomedical, Inc. and Aegeria Soft Tissue LLC  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104*       Cover Page Interactive                                                                             

  Filed herewith.  

   2  

No
Offer or Solicitation

This
Current Report does not constitute an offer to sell, or a solicitation of an offer to buy, or a recommendation to purchase, any securities
in any jurisdiction, or the solicitation of any vote, consent or approval in any jurisdiction in connection with the Business Combination
or any related transactions, nor shall there be any sale, issuance or transfer of any securities in any jurisdiction where, or to any
person to whom, such offer, solicitation or sale may be unlawful under the laws of such jurisdiction. This Current Report does not constitute
either advice or a recommendation regarding any securities. No offering of securities shall be made except by means of a prospectus meeting
the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.

Forward
Looking Statements

Certain
statements included in this Current Report are not historical facts but are forward-looking statements, including for purposes of the
safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking